Compare Procter & Gamble Health with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs WOCKHARDT - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH WOCKHARDT PROCTER & GAMBLE HEALTH/
WOCKHARDT
 
P/E (TTM) x 53.4 -18.8 - View Chart
P/BV x 4.8 1.0 487.4% View Chart
Dividend Yield % 9.8 0.0 252,214.3%  

Financials

 PROCTER & GAMBLE HEALTH   WOCKHARDT
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
WOCKHARDT
Mar-18
PROCTER & GAMBLE HEALTH/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs3,5491,012 350.7%   
Low Rs1,301532 244.8%   
Sales per share (Unadj.) Rs511.4355.9 143.7%  
Earnings per share (Unadj.) Rs61.3-60.3 -101.7%  
Cash flow per share (Unadj.) Rs74.0-46.8 -158.3%  
Dividends per share (Unadj.) Rs440.000.01 4,400,000.0%  
Dividend yield (eoy) %18.10 1,400,202.0%  
Book value per share (Unadj.) Rs927.8257.8 359.9%  
Shares outstanding (eoy) m16.60110.63 15.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.2 218.6%   
Avg P/E ratio x39.6-12.8 -309.1%  
P/CF ratio (eoy) x32.8-16.5 -198.5%  
Price / Book Value ratio x2.63.0 87.3%  
Dividend payout %717.90 -4,327,372.4%   
Avg Mkt Cap Rs m40,25785,379 47.2%   
No. of employees `0001.16.3 18.1%   
Total wages/salary Rs m1,3139,371 14.0%   
Avg. sales/employee Rs Th7,486.76,295.0 118.9%   
Avg. wages/employee Rs Th1,157.61,498.3 77.3%   
Avg. net profit/employee Rs Th897.2-1,066.3 -84.1%   
INCOME DATA
Net Sales Rs m8,49039,369 21.6%  
Other income Rs m2441,202 20.3%   
Total revenues Rs m8,73440,571 21.5%   
Gross profit Rs m1,48218 8,096.2%  
Depreciation Rs m2111,495 14.1%   
Interest Rs m02,555 0.0%   
Profit before tax Rs m1,514-2,830 -53.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m66-3,582 -1.8%   
Tax Rs m563257 218.9%   
Profit after tax Rs m1,017-6,669 -15.3%  
Gross profit margin %17.50 37,543.2%  
Effective tax rate %37.1-9.1 -409.0%   
Net profit margin %12.0-16.9 -70.7%  
BALANCE SHEET DATA
Current assets Rs m15,34333,796 45.4%   
Current liabilities Rs m1,96026,917 7.3%   
Net working cap to sales %157.617.5 902.2%  
Current ratio x7.81.3 623.4%  
Inventory Days Days4979 61.4%  
Debtors Days Days2889 31.9%  
Net fixed assets Rs m1,20939,664 3.0%   
Share capital Rs m166553 30.0%   
"Free" reserves Rs m15,23527,968 54.5%   
Net worth Rs m15,40128,522 54.0%   
Long term debt Rs m021,731 0.0%   
Total assets Rs m17,59581,620 21.6%  
Interest coverage xNM-0.1-  
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x0.50.5 100.0%   
Return on assets %5.8-5.0 -114.7%  
Return on equity %6.6-23.4 -28.3%  
Return on capital %10.3-7.7 -133.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,6369,807 16.7%   
Fx outflow Rs m4,3681,789 244.2%   
Net fx Rs m-2,7328,019 -34.1%   
CASH FLOW
From Operations Rs m-1,304684 -190.5%  
From Investments Rs m12,6976,302 201.5%  
From Financial Activity Rs m-301-7,695 3.9%  
Net Cashflow Rs m11,093-664 -1,670.6%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 2.3 791.3%  
FIIs % 1.0 7.7 13.0%  
ADR/GDR % 0.0 0.1 -  
Free float % 29.1 15.4 189.0%  
Shareholders   28,591 67,757 42.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  ELDER PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Oct 16, 2019 01:05 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - FRESENIUS KABI ONCO. COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS